FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

36877411000001101: Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113168601000001115 Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113168701000001113 Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has VMP Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has specific active ingredient Doravirine false Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Has specific active ingredient Doravirine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Delstrigo 100mg/300mg/245mg tablets (Merck Sharp & Dohme (UK) Ltd) 30 tablet Is a True Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start